fbpx Skip to main content

Member's Profile


10901 N. Torrey Pines Road Building 6-6210A
La Jolla,   CA
United States
Membership Info
Membership Type: Industry
Membership Since: 2018
Need to make an update to your Member Profile or have a question? Contact us here: [email protected]
About DrugCendR
Biotech Company
DrugCendR Inc. is a La Jolla -based biopharmaceutical company dedicated to developing next generation cancer therapies designed to overcome the barriers of drug delivery to solid tumors. The clinical-stage lead asset, CEND-1, activates a drug transport mechanism by means of tumor-selective molecular mimicry, leading to an enhanced uptake and deep solid tumor penetration of various types of co-administered anti-cancer agents. The proprietary technology has been studied and validated in more than 140 studies / publications, and is currently being studied in a multi-site trial in pancreatic cancer patients. Several other solid tumors trials are under preparation.
Related News
No related news posted by this Member